Remergin 1Million IU Injection
By Remergin
Rx
1 Injection in a Vial

Composition
Colistimethate Sodium(1Million IU)

Manufacturer - AstraZeneca
Corporate & Registered Office, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore

Expires on or after
May, 2026

liver
Limited information is accessible regarding the use of Remergin 1Million IU Injection in individuals with liver conditions. It is strongly advised to consult with your healthcare provider for personalized guidance before using this medication.

kidney
Remergin 1Million IU Injection requires caution in patients with kidney disease. Adjustments to the dosage may be necessary. Consult your doctor before using.

alcohol
When using Remergin 1Million IU Injection, consuming alcohol does not lead to any harmful side effects. It is advisable to be cautious during pregnancy.

driving
When using Remergin 1Million IU Injection, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if you experience these symptoms.

pregnancy
Remergin 1Million IU Injection may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will consider the risks and benefits before prescribing. It is essential to talk to your doctor about this.

breastfeeding
Remergin 1Million IU Injection is likely safe during breastfeeding according to limited human data, showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Polypeptides |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Cell membrane active agent |
₹952
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025